Express News | EyePoint Pharmaceuticals Inc - Topline Data for Phase 3 Pivotal Program Expected in 2026

ReutersDec 4 07:00 ET

Express News | EyePoint Announces First Patient Dosed in Second Global Phase 3 Lucia Clinical Trial of Duravyu™ for the Treatment of Wet Age-Related Macular Degeneration

ReutersDec 4 07:00 ET

EyePoint Pharmaceuticals Poised for Growth With Promising DME Treatment Duravyu

TipRanksDec 2 17:05 ET

Some EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shareholders Look For Exit As Shares Take 27% Pounding

Simply Wall StDec 1 07:12 ET

Selling EyePoint Pharmaceuticals Shares at a Lower Price Than Current Market Value May Have Been a Costly Mistake for Insiders

Simply Wall StNov 21 06:38 ET

Express News | EyePoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersNov 18 07:00 ET